Skip to main content
EPFL researchers have developed a biocompatible hydrogel with 10 times the adhesive strength of existing bioadhesives for surgical applications.
Technology
1 min read

EPFL researchers have developed a biocompatible hydrogel with 10 times the adhesive strength of existing bioadhesives for surgical applications.

Originally reported by glassalmanac.com

EPFL researchers have developed a biocompatible hydrogel with 10 times the adhesive strength of existing bioadhesives for surgical applications. Composed of 90% water, the material mimics natural tissue while resisting mechanical stresses like walking or running. For the additive manufacturing sector, this provides a reliable adhesive for in situ cell delivery, eliminating the need for invasive sutures. This transition to high-adhesion bio-inks will accelerate the adoption of real-time clinical tissue engineering. 🧬 #bioprinting #additivemanufacturing #medtech #innovation

Read Original

How This Connects

6 related events
  1. Same pattern

    EPFL researchers developed a room-temperature 3D printing process using enzyme-driven mineralization to create bone scaffolds that become load-bearing within 7 days.

  2. Same pattern

    Auxilium Biotechnologies is partnering with Starlab Space to deploy the AMP-1 bioprinting platform for scalable medical manufacturing in low Earth orbit.

  3. Same pattern

    PrintBio has joined a federal consortium led by WFIRM to receive up to 24.8 million USD from ARPA-H for bioprinting vascularized kidney tissue.

  4. This article

    EPFL researchers have developed a biocompatible hydrogel with 10 times the adhesive strength of existing bioadhesives for surgical applications.

  5. Same pattern

    Carnegie Mellon University secured a 28.5 million dollar ARPA-H award for the LIVE project, developing 3D-printed human liver patches.

  6. Same pattern

    Aspect Biosystems has expanded its partnership with Novo Nordisk to develop bioprinted islet therapies for Type 1 diabetes.

  7. Same pattern

    Nanochon secured $4.1M in funding to launch first-in-human trials for its 3D-printed knee implant.